Literature DB >> 311007

Direct evidence for loss of human suppressor cells during active autoimmune disease.

A J Strelkauskas, R T Callery, J McDowell, Y Borel, S F Schlossman.   

Abstract

These studies indicate that a regulatory subset of lymphocytes is missing in patients with juvenile rheumatoid arthritis but these patients have antibodies in their serum that react with normal T cells. This regulatory subset of T cells is, however, present in patients whose serum shows little or no reactivity with normal T cells. In addition, patients who are deficient in this regulatory subset of lymphocytes significantly higher numbers of cells secreting Ig as measured by a hemolytic plaque assay. The significance of these observations is twofold: first, they represent a positive relationship among the loss of regulation overproduction of immunoglobulin, and the presence of anti-T cell antibodies and second and perhaps of equal importance, is the indication that serum from patients with autoimmune diseases may give us a readily available reagent with which to dissect further functionally distinct subsets of normal T cells in man.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 311007      PMCID: PMC336282          DOI: 10.1073/pnas.75.10.5150

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Selective loss of suppressor cell function in New Zealand mice induced by NTA.

Authors:  L W Klassen; R S Krakauer; A D Steinberg
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

2.  Prognosis in Still's disease.

Authors:  B M ANSELL; E G BYWATERS
Journal:  Bull Rheum Dis       Date:  1959-05

3.  Loss of suppressor T-lymphocyte function in patients with systemic lupus erythematosus (SLE).

Authors:  C Morimoto
Journal:  Clin Exp Immunol       Date:  1978-04       Impact factor: 4.330

4.  Suppressor cell regulation of immune response to tumors: abrogation by adult thymectomy.

Authors:  C L Reinisch; S L Andrew; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

5.  Potentiation of a primary in vivo antibody response by alloantisera against gene products of the I region of the H-2 complex.

Authors:  M Pierres; R N Germain; M E Dorf; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

6.  Isolation and characterization of naturally occurring subclasses of human peripheral blood T cells with regulatory functions.

Authors:  A J Strelkauskas; V Schauf; B S Wilson; L Chess; S F Schlossman
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

7.  Two functionally distinct subpopulations of human T cells that collaborate in the generation of cytotoxic cells responsible for cell-mediated lympholysis.

Authors:  R L Evans; H Lazarus; A C Penta; S F Schlossman
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

8.  Specific enrichment of the suppressor T cell bearing I-J determinants: parallel functional and serological characterizations.

Authors:  K Okumura; T Takemori; T Tokuhisa; T Tada
Journal:  J Exp Med       Date:  1977-11-01       Impact factor: 14.307

9.  A suppressor T cell of the mixed lymphocyte reaction in man specific for the stimulating alloantigen. Evidence that identity at HLA-D between suppressor and responder is required for suppression.

Authors:  E G Engleman; A J McMichael; M E Batey; H O McDevitt
Journal:  J Exp Med       Date:  1978-01-01       Impact factor: 14.307

10.  A suppressor T cell in the human mixed lymphocyte reaction.

Authors:  A J McMichael; T Sasazuki
Journal:  J Exp Med       Date:  1977-08-01       Impact factor: 14.307

View more
  45 in total

Review 1.  Immunopathogenesis of juvenile rheumatoid arthritis: role of T cells and MHC.

Authors:  L I Sakkas; C D Platsoucas
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

2.  Increased prevalence of late stage T cell activation antigen (VLA-1) in active juvenile chronic arthritis.

Authors:  N Odum; N Morling; P Platz; B Hofmann; L P Ryder; C Heilmann; F K Pedersen; L P Nielsen; J Friis; A Svejgaard
Journal:  Ann Rheum Dis       Date:  1987-11       Impact factor: 19.103

3.  Activation of OKT4 suppressor cells in the autologous mixed lymphocyte reaction of patients with juvenile rheumatoid arthritis.

Authors:  K Oen; D Krzekotowska
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

Review 4.  Immunology of Guillain-Barré syndrome.

Authors:  I Steiner; O Abramsky
Journal:  Springer Semin Immunopathol       Date:  1985

5.  Monoclonal antibody investigation in rheumatoid arthritis: presence of a T cell subpopulation bearing a double marker.

Authors:  G Lapadula; M Covelli; R Numo; G Tricarico; G Amendoni; C Berlingerio
Journal:  Clin Rheumatol       Date:  1984-06       Impact factor: 2.980

6.  Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells.

Authors:  T Sakane; A D Steinberg; J P Reeves; I Green
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

7.  Suppressor-cell antibody in systemic lupus erythematosus. Possible mechanism for suppressor-cell dysfunction.

Authors:  A Sagawa; N I Abdou
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

8.  Autoimmune blood dyscrasias in five patients with hypogammaglobulinemia: response of neutropenia to vincristine.

Authors:  A D Webster; T A Platts-Mills; G Jannossy; M Morgan; G L Asherson
Journal:  J Clin Immunol       Date:  1981-04       Impact factor: 8.317

9.  Immunoregulatory T cells in the peripheral blood of patients with Bechterew's syndrome.

Authors:  O Vinje; J H Dobloug; O Førre; P Møller; O J Mellbye
Journal:  Ann Rheum Dis       Date:  1982-02       Impact factor: 19.103

10.  Mononuclear-cell subsets in human idiopathic crescentic glomerulonephritis (ICGN): analysis in tissue sections with monoclonal antibodies.

Authors:  I Stachura; L Si; T L Whiteside
Journal:  J Clin Immunol       Date:  1984-05       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.